CSTL R&D to Revenue
Castle Biosciences Inc · R&D to Revenue
CSTL R&D to Revenue
Latest reported14.04%period ending
CSTL Quarterly R&D/Revenue (34.51% → 14.04%)
Latest values, visible window
High-resolution chart · PNG
CSTL r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 14.045% | |
| 17.2421% | |
| 15.5327% | |
| 15.6064% | |
| 14.8362% | |
| 14.3065% | |
| 13.529% | |
| 14.3655% | |
| 16.2479% | |
| 18.9232% | |
| 19.6521% | |
| 21.0154% | |
| 26.5427% | |
| 34.2389% | |
| 29.4981% | |
| 29.4696% | |
| 34.2327% | |
| 40.0752% | |
| 37.7212% | |
| 31.9489% | |
| 29.8488% | |
| 25.8975% | |
| 26.4813% | |
| 20.0959% | |
| 21.2662% | |
| 16.7241% | |
| 17.9134% | |
| 10.2537% | |
| 12.2664% | |
| 15.9901% | |
| 9.9514% | |
| 34.8703% | |
| 29.1301% | |
| 34.5133% |